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ABSTRACT
The wwLigCSRre web server performs ligand-based
screening using a 3D molecular similarity engine. Its
aim is to provide an online versatile facility to assist
the exploration of the chemical similarity of families
of compounds, or to propose some scaffold hopping
from a query compound. The service allows the user
to screen several chemically diversified focused
banks, such as Kinase-, CNS-, GPCR-, Ion-chan-
nel-, Antibacterial-, Anticancer- and Analgesic-
focused libraries. The server also provides the
possibility to screen the DrugBank and DSSTOX/
Carcinogenic compounds databases. User banks
can also been downloaded. The 3D similarity
search combines both geometrical (3D) and physi-
cochemical information. Starting from one 3D ligand
molecule as query, the screening of such databases
can lead to unraveled compound scaffold as hits or
help to optimize previously identified hit molecules
in a SAR (Structure activity relationship) project.
wwLigCSRre can be accessed at http://bioserv.
rpbs.univ-paris-diderot.fr/wwLigCSRre.html.
INTRODUCTION
Ligand-based screening methods are now being conven-
tionally used in the early stages of a variety of drug dis-
covery projects to mine chemical databases with the aim of
identifying new hit compounds or optimizing leads. They
are based on the assumption that similar compounds are
likely to exhibit similar biological activities on a given
target. Depending on the data available about active
compounds, diﬀerent strategies have been proposed.
QSAR techniques attempt to build on top of a signiﬁcant
collection of compounds of known activity, a statistical
model that will be used to predict the activity of
new compounds (1). Similarity search techniques explicitly
address the question of the similarity between
compounds. Similarity can be addressed at diﬀerent
levels. Pharmacophore techniques (2) attempt to derive
key features that are shared by active compounds for
further use in the mining of collections. 2D similarity tech-
niques (3,4) use the topological description of compounds
to search for shared chemical patterns. 3D similarity
search, such as ROCS (5), MedSuMoLig (6), shaEP (7)
or Superimpose ´ (8) explicitlysearch for common shapes in
the compound conformations with in some cases a con-
sideration for chemistry. While 2D similarity tools, such
as LigandInfo (3) or ChemMine (4) represent eﬃcient
tools to screen large chemical databases, several studies
suggest that the legitimate wish for scaﬀold hopping is
more expected to be granted using 3D molecular similarity
screening tools (8,9).
An important aspect of in silico approaches to
drug design is the amount of potential compounds
to deal with. A growing number of chemical suppliers
provide free access to their numeric catalog (10)
(e.g. Aurora Fine Chemical http://www.auroraﬁnechemi
cals.com/, Asinex http://www.asinex.com/, Chembridge
http://www.chembridge.com, MayBridge http://www.
maybridge.com/). Recent initiatives have even provided
to the community a numeric collection of the main com-
mercial catalogs (11). Above all, the complexity and size of
the chemical space, estimated to more than 10
60 molecules
(12), makes it impossible to tackle with exhaustive search
tools. More and more studies (13–15) suggest that an eﬃ-
cient way to identify new chemical entities in drug discov-
ery projects is to design smaller and smarter chemical
libraries that should be chemically diversiﬁed and repre-
sentative of protein families.
In terms of tools available online, various web servers
such as sMOL (16), eMolecules www.emolecules.com,
QueryChem (17) already exist to mine chemical databases.
Yet, most of them use only 1D (SMILE) or 2D (SDF)
query-based searches including the chemical compound
providers themselves directly from their website e.g.
Aurora Fine Chemicals, MayBridge. FTrees (18–20) can
screen databases with more complex approach than just
2D similarity. FTrees is able to condense molecular
descriptions into a graph object and to search for actives
in large databases using graph similarity. Finally, several
web servers use a 3D description of chemical compounds.
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idate ligand structure or to locate all the instances of
one ligand within the structural databases (PDB).
Pharmagist (22) can perform pharmacophore construction
starting with several known drug-like binders of a given
protein target. The well-established PubChem server (23)
has very recently oﬀered the possibility to screen very rap-
idly the whole PubChem compound collections starting
with a 3D compound query. It does not however allow
to upload user compound collections and does not provide
either a superimposition of the hit molecules onto the
query compound. Finally, a dedicated 3D molecular sim-
ilarity screening service is Superimpose ´ (8) which proposes
two diﬀerent superimposition algorithms that can be
used to screen three diﬀerent databanks, Superdrug,
LigandDepot and the NCI collection. Superdrug (24)
represents a collection of active ingredients of essential
marketed drugs, LigandDepot (25) contains ligands that
are present within the PDB and NCI represents the 04
September 2007 version of the National Cancer Institute
database. However, Superimpose ´ execution times remain
consequent, on the order of 60h in some cases for large
banks.
wwLigCSRre online facility is built on top of a powerful
3D molecular similarity search engine (LigCSRre) to
screen focused chemical libraries. LigCSRre relies on the
CSR algorithm (26) that searches for the maximal
common substructure between two sets of unordered
coordinates. In LigCSRre, the search is in addition
driven by the information about the atomic nature,
bond and connectivity information, to deﬁne which pair-
ings are possible based on some physicochemical proper-
ties. In order to keep execution times reasonably low
(not exceeding the order of 1h), wwLigCSRre strategy is
to screen focused libraries of small size but preserving
chemical diversity. wwLigCSRre presently allows the
screening of 12 thematically focused libraries, including
family-based focused chemical libraries (GPCR, CNS,
Ion Channel, Kinase, Anticancer, Analgesic, and
Antibacterial), a chemically diverse subset of the diversity
set of the Chembridge database, three sets from the
Drugbank, (Small molecule, Approved, and Withdrawn)
and ﬁnally the CPDB Summary Tables (Carcinogenic
Potency Database) subset of the DSSTOX database.
This design makes wwLigCSRre particularly well suited
for fast scaﬀold hopping, lead identiﬁcation and
optimization.
CONCEPTS AND METHODS
Maximal substructure search
The similarity search engine, LigCSRre is an evolution of
the CSR algorithm originally developed by Petitjean (26)
that searches for the maximal 3D motif—or maximal
substructure (MSS)—common to two sets of coordinates.
The CSR algorithm searches for the largest set of atom
pairings between two clouds of atom coordinates—no
a priori pairings or a priori rules such as the knowledge
of the neighbors are required—using an iterative and sto-
chastic procedure. Each iteration starts from a random
initial superimposition, and iteratively maximizes the
number of pairings. Pairings are based on distance sort
of the N1
 N2 inter-atomic distances between the N1
atoms of the molecule 1 and the N2 atoms of the molecule
2. The array of the N1
 N2 distances is sorted by increasing
values. The ﬁrst atom pair, corresponding to the smallest
distance, is always included in the common motif. Next
pairs are included until a member of a pair already
included in the common motif occurs. The latter pair
is not included in the motif and the pairing terminates.
Then the complete sets of coordinates are best superim-
posed from the current pairings and the whole process
distance sorting/best ﬁt is iterated until no new pair
is accepted. This whole process is performed for a series
of random starting points and CSR returns the largest
motif identiﬁed.
In LigCSRre, we have implemented several additional
particular features. First, LigCSRre extends the set of
pairings at search convergence, in order to overcome a
limitation of the CSR algorithm that makes possible
that CSR stops to enlarge its MSS for an atom already
paired, but hiding subsequent pairs. Second, it considers
the fact that atomic properties of the pairs must be com-
patible. For this, LigCSRre embeds a regular expression
formalism that allows, for each atom, to deﬁne which
pairings are possible based on some physicochemical
properties (see next paragraph). This results in smaller
search space and increases search eﬃciency—LigCSRre
usually requires much less iterations than CSR.
To take into account the fact that authorized or forbid-
den pairings must be deﬁned in a way ﬂexible enough to be
adapted to a particular chemical context, we use the mol2
atom types, as assigned by open-babel (27). We use a three
level mechanism of regular expressions to deﬁne atomic
types compatible for pairing. The ﬁrst one is the default
level: default regular expressions authorize atoms to be
paired only with atom having the same exact atomic
type. The second level is the generic level: equivalence
classes are deﬁned. It is for instance possible to assert
that a carbon atom could be paired with any carbon,
but not oxygen or sulfur. A third level is the speciﬁc
level: regular expressions speciﬁc of a particular atom
can be deﬁned. For instance, it would be possible to
impose, for a speciﬁc carbon of known importance for
chemical activity, that it could match only an aromatic
carbon or a Nitrogen. The precedence order gives the
higher priority to the speciﬁc level, then to the generic
level, then to the default level. In wwLigCSRre, we use a
minimal set of rules for the generic level. More in detail,
the equivalence classes correspond (i) to carbons but
carbo-cations; (ii) sp2 Oxygen (0.2 and 0.co2 mol2
types); (iii) sulfoxide and sulfone Sulfur (S.o and S.o2);
(iv) sp2 and sp3 Sulfur; and (v) Nitrogen. The exact
detail of these equivalences is available on the
wwLigCSRre help page. For other atomic types, the
default rules only accept pairings for atoms of identical
atomic types. This set of rules has shown eﬃcient to search
large collections of compounds and retrieving compounds
of known similar activity (Quintus,F. et al., submitted for
publication).
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The LigCSRre algorithm is iteratively applied to each com-
pound of the bank. For each, it stores the number of bonds
(nB) identiﬁed as shared, where abond is denoted as shared
if both two atoms at bond extremities are paired on exit of
LigCSRre. It also stores the size of the pairing set (nP), and
the RMS deviation (RMSd) associated with these pairs.
Once all the compounds have been screened, they are
sorted using a cascading procedure: according to nB,
then to RMSd. We also calculate a z-score to roughly
assess the signiﬁcance of the match. It is based on the
number of bonds shared. Z ¼ð nBobs   nBexpÞ=
ﬃﬃ
ð
p
nBexpÞ,
where nBobs is the observed number of bonds paired,
nBexp is the expected number of bonds paired by chance,
that is calculated as nBcomp
  m, where nBcomp is the actual
number of bonds of the query compound, and m the aver-
age number of shared bonds over unrelated compounds.
Figure 1 illustrates the z-scores distributions for unrelated
compounds and 47 compounds known to share activities.
3D conformational variability
The performances of ligand screening based on 3D con-
formation depend on the number of conformations asso-
ciated with each compound. However, one must consider
the balance between conformational diversity, computa-
tional cost and search eﬃciency. Based on a previous
study (Quintus,F. et al., submitted for publication), we
use a maximum of 50 conformations per compound here.
Bank preparation
In order to limit the size of the banks to a tractable
number in the context on an online service, we generated
subsets of the collections when required. When chemical
diversity was required, like for the family-based focused
libraries, a combination of the tools Cactvs (28) (http://
www.xemistry.com) and Subset (29) was used. The ﬁnger-
prints calculated within Cactvs were submitted to a diver-
sity criterion such as having no pair of ligands with a
Tanimoto coeﬃcient above 0.85/0.8/0.75 depending on
the databank using the tool Subset. The slight Tanimoto
coeﬃcient variation was adjusted so to select a number
of compounds on the same magnitude per bank. From
the Aurora Fine Chemicals electronic catalog we have
integrated the following focused chemical libraries:
Analgesic, Antibacterial, Anticancer, Ion channel and
Kinase. From the Chembridge databases we have
extracted the CNS, GPCR and diversity subset to create
chemically diversiﬁed subsets. No chemical diversity crite-
rion has been applied to construct the three subsets of the
DrugBank, but they were ﬁltered for ADME properties
using the tool FAFDrugs2 (30) so to remove nondrug-like
compounds like injectable or non orally bioavailable
drugs. Finally, the CPDB subset from the DSSTOX data-
base was taken as it is. All the subsets were generated in
3D with Frog (31) and a maximum of 50 best scored
conformations per molecule was generated using the tool
MS-Dock (32). Table 1 gives an overview of the diﬀerent
databases available on the wwLigCSRre server.
INPUT/OUTPUT
The web interface proposed by wwLigCSRre is very
simple. Basically, the user will input a query, select a
bank to mine or upload it and run the search for similar
compounds. Despite for computational cost reasons, the
size of the collections available online in wwLigCSRre is
limited, depending on the nature of the query, the total
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Figure 1. Z-score distributions for active and unrelated compounds. For active compounds, the data plotted corresponds to 47 compounds actives on
cyclin-dependent kinase 2 (CDK2), neuraminidase, RNAse, coagulation factor Xa and thymidine kinase. Unrelated compounds correspond to the
ChemBridge diversity set (http://www.chembridge.com/), ADME/tox ﬁltered (38000 compounds).
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load, execution times may vary from several minutes up to
hours. So it is possible (but not mandatory) to specify an
email to get an alert on request termination.
The query consists in a single compound 3D conforma-
tion that must be in the mol2 format. Since the search is
sensitive to atom types we prefer not to perform any auto-
mated format interconversion that could result in unex-
pected atom typings. The query will be confronted to one
collection of conformations that can be either one of the
proposed banks or a user upload, up to a maximum of
either 500 compounds or 10000 conformations, whichever
is limiting. The proposed compound collections comprise
two small test sets that are made available for demonstra-
tion and 12 focused collections (Table 1), a number likely
to evolve in the future. Finally, the possibility to switch
the use of the generic rules oﬀ and to revert to strict atom
type pairing is left, although such option is strongly dis-
couraged since this impacts the pruning of the MSS algo-
rithm and results in increased CPU cost. It is also possible
to specify the maximal number nMax of compounds to get
returned in their 3D conformations.
At program termination, a list of the compounds ranked
by decreasing order is returned. Since the ranking is per-
formed on the basis on the number of bonds and atoms
paired, detailed results are provided per compound, along
withtheZ-scorevalueassociatedwiththenumberofbonds
shared with the query. The server will also supply the 3D
visualization of the superimpositions of the 10 best com-
pounds based on the JMol applet (http://www.jmol.org).
Finally, it is possible to download a mol2 ﬁle of the nMax
best compounds superimposed onto the query, for further
investigation. For each compound, it contains only the
conformation being the most similar to the query.
CASE STUDIES
We illustrate the use wwLigCSRre in three diﬀerent
contexts.
Structure activity relationship on IGF-1R
Structure activity relationship (SAR) studies rely on the
principle that similar compounds, and more speciﬁcally
molecules sharing a similar scaﬀold, are likely to share
binding properties to the same protein target. A recent
study (33) has identiﬁed several IGF-1R (insulin-like
growth factor-1 receptor) tyrosine kinase inhibitors.
About 30 new compounds have been identiﬁed sharing a
4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine scaﬀold with
various peripheral groups and displaying diﬀerent binding
activities and speciﬁcities toward the related JNK1
enzyme. When the shared scaﬀold can display various
conformations in the presence of diﬀerent peripheral
groups it becomes a diﬃcult task to evaluate the correct
disposition of them, making the impact on activity of these
groups harder to ﬁgure out. Figure 2 shows the optimized
superimposition by wwLigCSRre of all the SAR struc-
tures on one of them used as the query ligand. The present
ﬁgure helps to anticipate without the structure of
the bound protein target, which peripheral groups are
rather to be available for protein binding and those that
will generate steric stringency within the compound.
Although for most of the SAR cases 2D R-group analysis
can be suﬃcient to assess R-group variation, the use of
3D methods such as wwLigCSRre can provide a useful
superimposition to visualize the space occupancies of the
peripheral groups as it is done in 3D-QSAR projects.
Screening of the Aurora Fine Chemicals Kinase
focused library
As mentioned above, the use of 3D ligand-based tools on
family-based focused chemical libraries can represent an
eﬃcient way to tackle the diﬃcult problem of rapidly iden-
tifying new molecule binders on a given protein target.
In the case represented in Figure 3, we illustrate the
Table 1. Banks presently implemented in wwLigCSRre
Bank Number of compounds Tanimoto ADME-Filter
AFC
Analgesic 1587 0.8 No
Antibacterial 2069 None No
Anticancer 2048 0.8 No
Ion channel 775 0.8 No
Kinase 2283 0.8 No
CB
GPCR 940 0.85 No
CNS 2363 0.75 No
Diversity 2880 0.8 Yes
DB
Small molecule 942 None Yes
Approved 409 None Yes
Withdrawn 24 None Yes
DSSTOX
CPDB 1547 None None
aProvider: Aurora Fine Chemicals (AFC), ChemBridge (CB),
DrugBank (DB), DSSTOX. For each bank, we report the number of
compounds selected, the Tanimoto Diversity criterion threshold
(Tanimoto). Some banks were ﬁltered for ADME-Tox.
Figure 2. Superimposition of SAR results on IGF-1R.
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Chemicals Kinase focused library. A recent study (34)
has discovered a purine bioisostere Roscovitine analog
that we ran through wwLigCSRre on the Aurora Fine
Chemicals Kinase focused library. Among several interest-
ing hits, the ﬁrst ranked hit was correctly superimposed
onto the query ligand with an interesting level of shared
features such as the pyrazolo[1,5-a]-1,3,5-triazine scaﬀold
and some hydrophobic groups superimposed logically
onto the hydrophobic groups of the Roscovitine analog.
Example of scaffold hopping on CDK2 inhibitors
Finally, to illustrate the scaﬀold hopping capacities of
wwLigCSRre, we ran a quick run using the co-crystallized
ligand of PDB structure 1E9H (a CDK2 inhibitor) as the
query on 47 diversiﬁed ligands including 9 CDK2, 9 coag-
ulation factor Xa, 10 neuraminidase, 8 ribonuclease and
10 thymidine kinase inhibitors. The results shown on
Figure 4 illustrate the three ﬁrst CDK2 inhibitor hits
along with their z-scores. The three CDK2 hits, while
having 3 diﬀerent scaﬀolds, are superimposed onto the
indirubin-based ligand of 1E9H. Interestingly, this super-
imposition corresponds exactly to the crystallographic
alignment of the ligands in the crystals. This shows the
interest of using 3D methods over regular 2D similarity
search when expecting scaﬀold hopping.
DISCUSSION AND FUTURE WORK
The goal of wwLigCSRre is to provide an online versatile
facility to explore the 3D the chemical diversity of
compounds. Basically, it can be used for the 3D super-
imposition of small compounds. Applied to chemically
diversiﬁed focused banks, it can be used to provide some
Figure 3. A wwLigCSR run carried out using a Purine bioisostere
ligand as the query (a) detected a molecule hit (b) within the Aurora
Fine Chemicals Kinase focused library and proposed the corresponding
superimposition (c) with a z-score of 2.3.
Figure 4. wwLigCSR run on CDK2. 1E9H ligand was used as the query (a) and three known CDK2 inhibitors were correctly detected and
superimposed onto the query molecule (b), with respective z-scores of 3.353 (c), 2.708 (d) and 1.740 (e).
W508 Nucleic Acids Research, 2009, Vol. 37,WebServer issuescaﬀold hopping, as introduction to further investigations.
Applied to toxic or withdrawn compound libraries, it
could also help to identify compounds likely to exhibit
undesirable properties that could not easily be detected
using classical ADME/Tox facilities. Finally, applied to
patented compounds, it could help to identify compounds
too similar to these. One limitation of wwLigCSRre
comes from the limited number of compounds of the
banks proposed. Better rules to prune pairing exploration
could result in increased search eﬃciency and allow for
larger banks. Also, LigCSRre presently consider molecu-
lar similarity alone. The consideration of both molecular
similarities and discrepancies could result in increased
performance in bank mining.
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